Analysts Offer Predictions for Align Technology, Inc.’s Q1 2025 Earnings (NASDAQ:ALGN)

Align Technology, Inc. (NASDAQ:ALGN) – Stock analysts at William Blair increased their Q1 2025 earnings per share estimates for Align Technology in a research report issued on Wednesday, April 24th. William Blair analyst B. Vazquez now anticipates that the medical equipment provider will post earnings per share of $1.93 for the quarter, up from their previous forecast of $1.78. The consensus estimate for Align Technology’s current full-year earnings is $7.69 per share. William Blair also issued estimates for Align Technology’s Q2 2025 earnings at $2.21 EPS, Q3 2025 earnings at $2.34 EPS and Q4 2025 earnings at $2.53 EPS.

Align Technology (NASDAQ:ALGN) last issued its earnings results on Wednesday, January 31st. The medical equipment provider reported $1.91 EPS for the quarter, topping the consensus estimate of $1.78 by $0.13. The firm had revenue of $956.73 million during the quarter, compared to analysts’ expectations of $928.57 million. Align Technology had a return on equity of 14.15% and a net margin of 11.80%.

Other research analysts have also recently issued reports about the company. Piper Sandler reissued an “overweight” rating and set a $375.00 price objective (up from $355.00) on shares of Align Technology in a report on Thursday. Morgan Stanley lifted their price objective on Align Technology from $344.00 to $360.00 and gave the company an “overweight” rating in a report on Thursday. Leerink Partnrs reissued a “market perform” rating on shares of Align Technology in a report on Monday, February 26th. UBS Group lifted their price objective on Align Technology from $280.00 to $320.00 and gave the company a “neutral” rating in a report on Monday, April 15th. Finally, SVB Leerink initiated coverage on Align Technology in a research note on Monday, February 26th. They issued a “market perform” rating and a $310.00 target price for the company. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $353.00.

Align Technology Stock Performance

Shares of NASDAQ ALGN opened at $309.02 on Monday. The stock has a market cap of $23.25 billion, a PE ratio of 50.91, a PEG ratio of 5.53 and a beta of 1.65. The business has a fifty day moving average of $313.38 and a two-hundred day moving average of $270.82. Align Technology has a 52-week low of $176.34 and a 52-week high of $413.20.

Insider Activity

In related news, EVP Emory Wright sold 2,524 shares of Align Technology stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $287.45, for a total value of $725,523.80. Following the completion of the sale, the executive vice president now directly owns 709 shares in the company, valued at $203,802.05. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, EVP Emory Wright sold 2,524 shares of Align Technology stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $287.45, for a total value of $725,523.80. Following the completion of the sale, the executive vice president now directly owns 709 shares in the company, valued at $203,802.05. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Joseph Lacob sold 15,000 shares of Align Technology stock in a transaction dated Thursday, February 29th. The stock was sold at an average price of $303.22, for a total value of $4,548,300.00. Following the completion of the sale, the director now owns 131,994 shares of the company’s stock, valued at $40,023,220.68. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 27,524 shares of company stock worth $8,403,924. 0.64% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Align Technology

Several institutional investors have recently modified their holdings of ALGN. Mather Group LLC. acquired a new position in shares of Align Technology during the 1st quarter worth about $26,000. Huntington National Bank grew its position in shares of Align Technology by 94.9% during the 3rd quarter. Huntington National Bank now owns 115 shares of the medical equipment provider’s stock worth $35,000 after buying an additional 56 shares during the period. Compagnie Lombard Odier SCmA acquired a new position in shares of Align Technology during the 3rd quarter worth about $61,000. Orion Capital Management LLC acquired a new position in shares of Align Technology during the 3rd quarter worth about $61,000. Finally, Lindbrook Capital LLC grew its position in shares of Align Technology by 47.2% during the 1st quarter. Lindbrook Capital LLC now owns 187 shares of the medical equipment provider’s stock worth $61,000 after buying an additional 60 shares during the period. 88.43% of the stock is currently owned by institutional investors and hedge funds.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.